Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Nitromed
The overall objective is confirmation of BiDil's Safety and Efficacy in African-American (AFA) Patients with Moderate to Severe Symptomatic Heart Failure.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
African American male or female 18 years or older.
NYHA Class 3 \& 4.
Have either a resting LVEF less than or equal to 35% (by any method) or a resting LVIDD greater than 2.9 cm/m2 BSA (or greater than 6.5 cm) with LVEF less than 45% (by echocardiogram).
Clareo Health | African-American Heart Failure Trial
